Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization

PURPOSE: To determine the clinical outcomes of lenvatinib plus PD-1 inhibitor combined with microwave ablation (MWA) and synchronous transarterial chemoembolization (TACE) in patients with progressive hepatocellular carcinoma (pHCC). MATERIALS AND METHODS: This retrospective study enrolled pHCC pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Qin, Huang, Peng, Zhang, Zihan, Zhang, Wen, Liu, Lingxiao, Yan, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599250/
https://www.ncbi.nlm.nih.gov/pubmed/37885925
http://dx.doi.org/10.2147/JHC.S426308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599250/
https://www.ncbi.nlm.nih.gov/pubmed/37885925
http://dx.doi.org/10.2147/JHC.S426308

Ejemplares similares